HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven J Scheinman Selected Research

Dent Disease

1/2020Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.
1/2009OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability.
2/2005Dent Disease with mutations in OCRL1.
5/2004Evidence for genetic heterogeneity in Dent's disease.
1/2004Inherited hypercalciuric syndromes: Dent's disease (CLC-5) and familial hypomagnesemia with hypercalciuria (paracellin-1).
4/2003Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patients.
12/2002Responsiveness of hypercalciuria to thiazide in Dent's disease.
1/2002Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven J Scheinman Research Topics

Disease

8Dent Disease
01/2020 - 01/2002
5Hypercalciuria
05/2006 - 12/2002
4Nephrolithiasis
05/2004 - 12/2002
3Proteinuria
12/2016 - 01/2002
3Renal Insufficiency (Renal Failure)
03/2014 - 01/2004
3Kidney Calculi (Kidney Stone)
01/2012 - 12/2002
3Fanconi Syndrome (Syndrome, Fanconi)
01/2004 - 01/2002
2Cystic Kidney Diseases (Cystic Kidney Disease)
03/2014 - 03/2013
2Cataract (Cataracts)
01/2009 - 02/2005
1Chronic Renal Insufficiency
01/2020
1Agenesis of Cerebellar Vermis
09/2009
1Oculocerebrorenal Syndrome (Lowe Syndrome)
02/2005
1Intellectual Disability (Idiocy)
02/2005
1Nephrocalcinosis
05/2004
1Hematuria
05/2004
1Hypophosphatemia
05/2004
1Hypokalemia
01/2004
1Bone Resorption
07/2003
1Osteoporosis
01/2003

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
12/2016 - 07/2002
3CalciumIBA
01/2004 - 12/2002
2CreatinineIBA
01/2020 - 01/2012
2CytosineIBA
03/2014 - 03/2013
2MagnesiumIBA
01/2012 - 01/2004
2Calcitriol Receptors (Calcitriol Receptor)IBA
05/2006 - 07/2003
2Chloride Channels (Chloride Channel)IBA
02/2005 - 01/2004
2CLC-5 chloride channelIBA
05/2004 - 12/2002
1SteroidsIBA
12/2016
1Mucin-1 (CA 15-3 Antigen)IBA
03/2013
1SodiumIBA
01/2012
1ChloridesIBA
01/2012
1Oxalic Acid (Disodium Oxalate)IBA
01/2012
1Calcium CitrateIBA
01/2012
1Uric Acid (Urate)IBA
01/2012
1NitrogenIBA
01/2012
1Urea (Carbamide)FDA LinkGeneric
01/2012
1Phosphorus (Red Phosphorus)IBA
01/2012
1PotassiumIBA
01/2012
1Sulfates (Sulfates, Inorganic)IBA
01/2012
1Nonsense Codon (Nonsense Mutation)IBA
01/2009
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2005
1DNA (Deoxyribonucleic Acid)IBA
05/2004
1SaltsIBA
01/2004
1CationsIBA
01/2004
1Proton-Translocating ATPases (ATPase, H+)IBA
04/2003
1Sodium-Phosphate Cotransporter Proteins (Sodium-Phosphate Cotransporter)IBA
01/2003
1Chlorthalidone (Chlortalidone)FDA LinkGeneric
12/2002
1Calcium OxalateIBA
12/2002
1calcium phosphateIBA
12/2002
1ThiazidesIBA
12/2002
1Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
12/2002
1DiureticsIBA
12/2002
1LigandsIBA
01/2002
1Low Density Lipoprotein Receptor-Related Protein-2IBA
01/2002

Therapy/Procedure

2Therapeutics
01/2020 - 12/2002
1Transplantation
03/2014
1Slit Lamp
01/2009